| scholarly article | Q13442814 |
| P50 | author | Sabah Alharazy | Q42390645 |
| P2093 | author name string | Oteh Maskon | |
| Abdul Halim Abdul Gafor | |||
| Marlyn Mohd | |||
| Syed Zulkifli Syed Zakaria | |||
| Rashidi Saidin | |||
| Norella Kong | |||
| P2860 | cites work | Contrast-induced nephropathy | Q28293754 |
| Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury | Q33830710 | ||
| Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial | Q34176397 | ||
| Hospital-acquired renal insufficiency | Q34522737 | ||
| N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. | Q34542789 | ||
| N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis | Q34722709 | ||
| Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature | Q35670852 | ||
| Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies | Q36136330 | ||
| Contrast-induced nephropathy: a clinical and evidence-based approach | Q36445067 | ||
| Emerging biomarkers of acute kidney injury | Q36803577 | ||
| Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. | Q37087937 | ||
| The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis | Q38063188 | ||
| Nephrotoxicity of contrast media | Q38714594 | ||
| Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. | Q42170160 | ||
| Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study | Q42278871 | ||
| Impact of Contrast-Induced Nephropathy and Cardiovascular Events by Serum Cystatin C in Renal Insufficiency Patients Undergoing Cardiac Catheterization | Q42858592 | ||
| Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention | Q43614019 | ||
| Acetylcysteine for prevention of contrast nephropathy: meta-analysis | Q43799903 | ||
| Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). | Q43865327 | ||
| Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention | Q43993720 | ||
| Acetylcysteine and contrast agent-associated nephrotoxicity | Q44054777 | ||
| Nephrotoxic effects in high-risk patients undergoing angiography | Q44305026 | ||
| GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function. | Q44314100 | ||
| Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials | Q44719854 | ||
| Analytical interference of drugs in clinical chemistry: II--The interference of three cephalosporins with the determination of serum creatinine concentration by the Jaffé reaction | Q44946950 | ||
| Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables | Q45201786 | ||
| Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. | Q45209748 | ||
| Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions | Q45240001 | ||
| Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study | Q46842288 | ||
| Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? | Q46977079 | ||
| Kidney NGAL is a novel early marker of acute injury following transplantation | Q46984063 | ||
| Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. | Q51299964 | ||
| P433 | issue | 3 | |
| P921 | main subject | angiography | Q468414 |
| contrast-induced nephropathy | Q1783300 | ||
| P304 | page(s) | 216-223 | |
| P577 | publication date | 2013-01-31 | |
| P1433 | published in | Angiology | Q4763277 |
| P1476 | title | Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography | |
| P478 | volume | 65 |
| Q44623303 | "Is it possible to prevent acute kidney injury in the patients who underwent contrast medium?". |
| Q38261342 | 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms: a useful biomarker of AAA rupture risk |
| Q38250041 | Contrast-Induced Nephropathy: An "All or None" Phenomenon? |
| Q37609407 | Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study). |
| Q35689680 | No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT. |
| Q92326979 | Potential Role of Vitamin C Intracoronary Administration in Preventing Cardiac Injury After Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction |
| Q50958511 | Role of Urinary Neutrophil Gelatinase-Associated Lipocalin for Predicting the Severity of Renal Functions in Patients With Autosomal-Dominant Polycystic Kidney Disease. |
| Q36158274 | Role of urine neutrophil gelatinase-associated lipocalin in the early diagnosis of amphotericin B-induced acute kidney injury |
| Q93159805 | Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome |
| Q40395996 | Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease |
Search more.